UCSF Hospitalist, Director of UCSF Hospital Medicine Fellowship
Internal Medicine
Dr. Margaret C. Fang, MD
|
|
Give Review
Margaret Fang practices Internal Medicine. She graduated from Northwestern University Feinberg School of Medicine. Northwestern University Feinberg School of Medicine has a rank of 19 in research and a 29 in primary care She has 1 awards "CMS Meaningful Use Stage 1 Certification". Dr. Margaret C. Fang is a published doctor and has 34 publications published. The lastest was: 'Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.' She accepts all Medicare patients.
Publications
- Comparison of Frequency and Outcome of Major Gastrointestinal Hemorrhage in Patients With Atrial Fibrillation on Versus Not Receiving Warfarin Therapy (from the ATRIA ...
- Care as a continuum: Will hospital outcomes be influenced by outpatient care?
- Digoxin and Risk of Death in Adults with Atrial Fibrillation: The ATRIA-CVRN Study.
- Effect of Selective Serotonin Reuptake Inhibitors on Bleeding Risk in Patients With Atrial Fibrillation Taking Warfarin.
- Trends in Stroke Rates, Risk, and Outcomes in the United States, 1988-2008.
- Internal medicine rounding practices and the accreditation council for graduate medical education core competencies.
- Long-term survival after ischemic stroke in patients with atrial fibrillation.
- A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing.
- BOOST: Evidence needing a lift.
- Assessing bleeding risk in patients taking anticoagulants.
- Atrial fibrillation: stroke prevention in older adults.
- Thirty-Day Mortality After Ischemic Stroke and Intracranial Hemorrhage in Patients With Atrial Fibrillation On and Off Anticoagulants.
- Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinic...
- Performance of an online translation tool when applied to patient educational material.
- Selecting the optimal stroke prevention therapy in atrial fibrillation.
- Hazards of hospitalization: more than just "never events".
- A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.
- Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery.
- Anticoagulation in people with atrial fibrillation.
- Statistical design of personalized medicine interventions: the Clarification of Optimal Anticoagulation through Genetics (COAG) trial.
- Warfarin discontinuation after starting warfarin for atrial fibrillation.
- CHA2DS2-VASc risk scheme: not ready for clinical use.
- Trends in thrombolytic use for ischemic stroke in the United States.
- Venous thromboembolism prophylaxis in the United States: still room for improvement.
- Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.
- Rates and predictors of plans for inferior vena cava filter retrieval in hospitalized patients.
- Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study.
- The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.
- Trends in catheter ablation for atrial fibrillation in the United States.
- The net clinical benefit of warfarin anticoagulation in atrial fibrillation.
- Language, literacy, and characterization of stroke among patients taking warfarin for stroke prevention: Implications for health communication.
- Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (AT...
- Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study.
Schools
Northwestern Center Feinberg School of Medicine
Beth Isreal Deaconess Med Center
Ma Genl Hospital
Doctors Specialties
- Internal Medicine
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Beth Israel Deaconess Medical Center -
Northwestern University Feinberg School of Medicine
Hospital
-
San Francisco General Hospital and Trauma Center -
UCSF Medical Center
Drug Facts
| NPI NUMBER | 1417911462 | |
| NPPES Provider LastName | FANG | |
| NPPES Provider FirstName | MARGARET | |
| NPPES Provider ZIPCode | 941432208 | |
| NPPES Provider State | CA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 296.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1417911462 |
| Last Name Of The Provider | FANG |
| First Name Of The Provider | MARGARET |
| View All |
Similar Doctors
|
|
Dr. Louise C. Walter, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Mirwais Amoni, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marcus D. Zachary, DO |
|
Dr. Debra D. Osman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Victoria A. Behrman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth S. Harleman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kirsten P. Marcus, MD |
|
Dr. Bennett Zier, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sansan M. Tin, MD |
|
|
Katherine D. Wysham |